Skip to content

Dr. Thomas De Smedt

Active Private limited companyfounded 2010active for 16 yearsPierstraat 355G, 2550 KontichKBO/BCE: BE 0822.824.472

Lifetime

16 annual accounts with figures on one time axis
peak of €319,416 in 2024
€301,693▼ 5.5%
peak of €178,525 in 2024
€164,485▼ 7.9%
peak of €1.2m in 2022
€943,517▲ 6.5%
€527,287▼ 15.8%
Board2 names since 2010
2 directors and 1 other
Documentsfilings and deeds
31-07-2026on the last day
2025micro format
Dividend €107,227Debts from €626,200 to €527,287

Key points

from the 2025 annual accounts

Equity

€943,517 ▲ 6.5%
886,2592024+164,485Profit-107,227Dividend943,5172025

Dr. Thomas De Smedt paid out €107,227 in dividends. That is 65% of the 2025 profit.

Turnover

≈ €450,000 estimated

The micro format states no turnover.

Position in the sector

€943,517

More equity than 92% of companies in human health. The sector median is €125,188, over 21,399 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,827 companies had the same profile as Dr. Thomas De Smedt has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,827 companies, not a prediction for Dr. Thomas De Smedt. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director, since 25-10-2023
  • deed of 20-01-2014

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0822824472
changes role from manager to director Gazette deed
reappointed as director General meeting of 30-06-2020 · Gazette deed
Capital decrease of €63,000 to €18,600 The capital fell from €81,600 to €18,600 · Gazette deed
All 30 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Thomas De Smedt Kontich €1.5m €301,693 64.1% -
Dr. De Meyer Tim - cardiologie Nijlen €1.5m €293,436 86.6% -
ELANIE Vosselaar €1.4m €330,697 52.8% 0
DR. BENEDICTE GENIETS, ANESTHESIE Antwerp €1.4m €312,966 55.0% -
DR. PHILIP MATTHYSSEN Brasschaat €1.3m €312,306 96.7% -
DOKTERSPRAKTIJK ROEL MEEUS Sint-Katelijne-Waver €1.7m €323,356 97.6% -
DOKTER STEVEN VISSERS Lier €1.3m €288,318 78.2% 0

These companies have the same main activity as Dr. Thomas De Smedt: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.3m and €1.7m, founded between 2008 and 2012.

Official details

Source: KBO
Status
Active since 01-02-2010Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.274.184.8932550 Kontich, registered on 01-02-2010
Financial year end
31 December
Peppol
Reachable since 21-10-2026
Company details

Annual accounts 2025

€1.5m▼ 2.8%
Filing
Filed on 31-07-2026, on the last day of the filing period
Financials

Insights on Dr. Thomas De Smedt

Dr. Thomas De Smedt files the micro format. That format states no turnover. The gross margin rose from €75,995 in 2010 to €301,693 in 2025.

The balance sheet grew most from 2011 to 2013 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Thomas De Smedt

What is the company number of Dr. Thomas De Smedt?
The company number of Dr. Thomas De Smedt is 0822.824.472. The VAT number is the same number with BE in front: BE 0822.824.472.
Where is Dr. Thomas De Smedt based?
The registered office is at Pierstraat 355G, 2550 Kontich.Company details
What does Dr. Thomas De Smedt do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Thomas De Smedt?
Dr. Thomas De Smedt is a private limited company (BV).
When was Dr. Thomas De Smedt founded?
Dr. Thomas De Smedt was founded on 01-02-2010.
Is Dr. Thomas De Smedt still active?
Yes, Dr. Thomas De Smedt is an active enterprise in the KBO register.
What is the turnover of Dr. Thomas De Smedt?
The turnover in financial year 2025 is about €450,000. This figure is estimated from the gross margin of €301,693 and 31 comparable companies (NACE 86220). It probably lies between €400,000 and €630,000.Financials
Is Dr. Thomas De Smedt profitable?
In financial year 2025, Dr. Thomas De Smedt made a profit of €164,485.
Where can I find the annual accounts of Dr. Thomas De Smedt?
Dr. Thomas De Smedt filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Thomas De Smedt due?
Dr. Thomas De Smedt must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.